<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02516475</url>
  </required_header>
  <id_info>
    <org_study_id>055570</org_study_id>
    <nct_id>NCT02516475</nct_id>
  </id_info>
  <brief_title>Effects of Zinc Supplementation on Anthropometric Factors, Apelin and Inflammatory Markers in Obese Individuals</brief_title>
  <official_title>Effects of Zinc Supplementation on Weight, Body Mass Index (BMI), Waist Circumference, Fat Mass and Lean Mass, Apelin and Inflammatory Markers in Obese Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Nutrition and Food Technology Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Nutrition and Food Technology Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the effects of zinc supplement on anthropometric factors, Apelin and inflammatory
      markers in obese individuals, 50 obes person who referred to Diet and Nutrition clinic of
      Shahid Beheshti University of Medical Sciences will be randomly allocated to receive 50 mg
      zinc capsules or placebos for 15 weeks; both groups will be advised to adherence the
      investigators' diet . At the first and the end of the intervention,weight, body mass index
      (BMI), waist circumference, fat mass and lean body mass, concentration of zinc, albumin,
      hs-CRP, TNF-Î± and plasma apelin will be assessed and compared between groups.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>weight</measure>
    <time_frame>15 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>zinc sulfate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 zinc sulfate capsule for 15 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>starch</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1 corn starch capsule for 15 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>zinc sulfate</intervention_name>
    <description>1 zinc sulfate capsule for 15 weeks</description>
    <arm_group_label>zinc sulfate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>corn starch</intervention_name>
    <description>1 corn starch capsule for 15 weeks</description>
    <arm_group_label>starch</arm_group_label>
    <other_name>placebo</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age of 18 to 45 years

          -  Non-smoking

          -  Body Mass Index (BMI) more than 30

        Exclusion Criteria:

          -  Pregnancy, lactation or menopause in women

          -  History of liver disease, kidney, thyroid, diabetes and other metabolic diseases

          -  Use of drugs interfering with lipid profile, blood-thinning drugs, beta-blockers

          -  Patients with immune deficiency

          -  Use of zinc, calcium and iron supplement in the last 2 months

          -  Use of weight loss medication or special diet

          -  Following program to lose weight in recent 2 months

          -  Recent surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Azita Hekmatdoost, MD,PHD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Nutrition and Food Technology Research Institute</affiliation>
  </overall_official>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 30, 2015</study_first_submitted>
  <study_first_submitted_qc>August 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2015</study_first_posted>
  <last_update_submitted>August 3, 2015</last_update_submitted>
  <last_update_submitted_qc>August 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 6, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Nutrition and Food Technology Institute</investigator_affiliation>
    <investigator_full_name>Dr Azita Hekmatdoost</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Zinc</mesh_term>
    <mesh_term>Zinc Sulfate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

